209 results on '"Yang, Jeng-Fu"'
Search Results
2. A people-centered decentralized outreach model toward HCV micro-elimination in hyperendemic areas: COMPACT study in SARS Co–V2 pandemic
3. FRI-280 Dynamic of cardiometabolic components are highly correlated with the risk of hypertension and diabetes among patients with metabolic dysfunction-associated steatotic liver disease
4. FRI-271 Hepatitis C infection increases the risk of new-onset HTN and DM among patients with metabolic dysfunction-associated steatotic liver disease
5. Air pollution associate with advanced hepatic fibrosis among patients with chronic liver disease
6. Air pollution associate with advanced hepatic fibrosis among patients with chronic liver disease.
7. The Efficacy of Anthropometric Indicators in Predicting Non-Alcoholic Fatty Liver Disease Using FibroScan® CAP Values among the Taiwanese Population
8. Fasting sugar, blood pressure, and uric acid are factors related to positive proteinuria and an impaired eGFR
9. Community-centered Disease Severity Assessment of Metabolic Dysfunction-associated Fatty Liver Disease
10. Effect of music on level of anxiety in patients undergoing colonoscopy without sedation
11. Epidemiology of Chronic Hepatitis B Infection in the Cohort of College Students with Vaccination in Taiwan
12. Nonalcoholic fatty liver disease severity is associated with the ratios of total cholesterol and triglycerides to high-density lipoprotein cholesterol
13. The Efficacy of Anthropometric Indicators in Predicting Non-Alcoholic Fatty Liver Disease Using FibroScan ® CAP Values among the Taiwanese Population.
14. Amelioration of glucose intolerance through directly acting antiviral agents in chronic hepatitis C cirrhotic patients without overt diabetes
15. Occupational risks of esophageal cancer in Taiwanese men
16. Waist circumference, body mass index, serum uric acid, blood sugar, and triglyceride levels are important risk factors for abnormal liver function tests in the Taiwanese population
17. Host interleukin-28B genetic variants versus viral kinetics in determining responses to standard-of-care for Asians with hepatitis C genotype 1
18. Low disease awareness as a contributing factor to the high prevalence of hepatitis C infection in Tzukuan, a hyperendemic area of southern Taiwan
19. Efficacy and Safety of Pegylated Interferon Combined with Ribavirin for the Treatment of Older Patients with Chronic Hepatitis C
20. Performance characteristics of a combined hepatitis C virus core antigen and anti–hepatitis C virus antibody test in different patient groups
21. A People-Centered Decentralized Outreach Model Toward HCV Micro-Elimination in Hyperendemic Areas: COMPACT Study in SARS Co-V2 Pandemic
22. Viral Hepatitis Infections in Southern Taiwan: A Multicenter Community-based Study
23. Food intake and the occurrence of squamous cell carcinoma in different sections of the esophagus in Taiwanese men
24. Comparison of Clinical Application of the Abbott HBV PCR Kit and the Versant HBV DNA 3.0 Test to Measure Serum Hepatitis B Virus DNA in Taiwanese Patients
25. Hepatitis C Virus Infection And Metabolic Syndrome—A Community-Based Study in an Endemic Area of Taiwan
26. The safety and efficacy of peginterferon plus ribavirin in hepatitis C patients concomitant with malignancy other than hepatocellular carcinoma: a multicenter study
27. Interferon-associated hepatic steatosis is related to discrepancies in biochemical and virological responses of chronic hepatitis C to IFN-based therapy
28. Thyroid autoantibodies and dysfunction do not impact the treatment efficacy of peginterferon and ribavirin combination therapy in chronic hepatitis C
29. Lower hemoglobin concentrations and subsequent decline in kidney function in an apparently healthy population aged 60 year and older
30. Comparison of adverse effects related to pegylated interferon-based therapy for patients with chronic hepatitis B and chronic hepatitis C in Taiwan
31. Serum hs-CRP was correlated with treatment response to pegylated interferon and ribavirin combination therapy in chronic hepatitis C patients
32. Significant amelioration of hepatitis C virus infection in a hyperendemic area: longitudinal evidence from the COMPACT Study in Taiwan
33. Qualitative Application of COBAS AMPLICOR HCV Test Version 2.0 Assays in Patients with Chronic Hepatitis C Virus Infection and Comparison of Clinical Performance with Version 1.0
34. The outcomes of glucose abnormalities in pre-diabetic chronic hepatitis C patients receiving peginterferon plus ribavirin therapy
35. Pegylated interferon plus ribavirin therapy improves pancreatic β-cell function in chronic hepatitis C patients
36. Hepatic Akt expression correlates with advanced fibrosis in patients with chronic hepatitis C infection
37. Serum visfatin is correlated with disease severity and metabolic syndrome in chronic hepatitis C infection
38. Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients
39. Treatment efficacy for patients with chronic hepatitis C and preexisting hepatocellular carcinoma by directly acting antivirals
40. Higher NAFLD fibrosis score is associated with impaired eGFR
41. Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis
42. Early identification of achieving a sustained virological response in chronic hepatitis C patients without a rapid virological response
43. Significant correlations between severe fatty liver and risk factors for metabolic syndrome
44. The outcomes of glucose abnormalities in chronic hepatitis C patients receiving interferon‐free direct antiviral agents
45. Hepatitis D virus infections among injecting drug users with and without human immunodeficiency virus infection in Taiwan
46. Distinct subpopulations of hepatitis C virus infectious cells with different levels of intracellular hepatitis C virus core protein
47. The performance of acoustic radiation force impulse imaging in predicting liver fibrosis in chronic liver diseases
48. Anti-HIV seropositivity was related to HBsAg seropositivity among injecting drug users in Taiwan
49. Baseline gamma-glutamyl transferase levels strongly correlate with hepatocellular carcinoma development in non-cirrhotic patients with successful hepatitis C virus eradication
50. Hepatitis C Virus Infection among Injection Drug Users with and without Human Immunodeficiency Virus Co-Infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.